Press release
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Delivery System In XAFTY Improves Effectiveness Against Dengue
Dengue Treatment
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to mosquito propagation, deficient measures for vector control, and population inflation in areas at high risk. Dengue treatments lessen the number of dengue cases by facilitating prompt medical intervention, mitigating intense symptoms, stopping complications, and containing the spread of the disease through improved patient results and boosting public health awareness. For example, the Centers for Disease Control and Prevention, a government agency based in the US, reported in 2023 that over 4.6 million dengue fever cases in the Americas, alongside roughly 4,000 mortalities. This was an increase of 13% when compared with the same timeframe in 2022 and a notable escalation from prior years. Therefore, the escalating dengue case count is fueling the expansion of the market for dengue treatments.
Get Your Dengue Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report
What is the future CAGR of the dengue treatment market, and how will it impact industry expansion?
The market size of dengue treatment has witnessed a swift expansion in the last few years. The projection suggests an increase from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. The surge during the preceding period is primarily due to advancements in diagnostic instruments, initiatives by governments and non-governmental organizations, the establishment of epidemiological surveillance systems, hefty investment in research and development, and significant community education measures.
The size of the treatment market for dengue is anticipated to experience swift expansion in the coming years, reaching a value of $3.64 billion in 2029, with a compound annual growth rate (CAGR) of 11.6%. The growth projected for this period can be credited to factors such as universal vaccine development, increased accessibility to vaccines, collaborations between public and private sectors, the rise of telemedicine, and improvements in the policy framework. The forecast period also points to significant trends such as the development of next-gen dengue vaccines, drug discovery through AI, sophisticated contact tracing mechanisms, 3D-printed vaccines, and the utilization of CRISPR for virus targeting.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp
What are the most significant trends transforming the dengue treatment market today?
Large corporations active in the dengue therapy industry are concentrating their efforts on creating solutions such as extensive antiviral drugs to better treat the disease, lessen its severity, and simultaneously tackle several forms of the dengue virus. A broad-spectrum antiviral medication implies a drug that is efficient in combating a variety of viruses, as opposed to one that only targets a specific virus type. As an example, Hyundai Pharmaceutical Co. Ltd., a pharmaceutical producer from South Korea, introduced a revolutionary antiviral with wide range named XAFTY in September 2024. This antiviral is designed to combat various viral infections, including COVID-19 and dengue fever. Its attributes include an innovative formulation enhancing the absorption and effectiveness of niclosamide, safety and efficacy backed up by clinical trials, versatility against a range of RNA viruses, swift response, and potential fast deployment to areas experiencing public health emergencies.
Which key market segments comprise the dengue treatment market and drive its revenue growth?
The dengue treatment market covered in this report is segmented -
1) By Type: Vaccines, Acetaminophen
2) By Route Of Administration: Parenteral, Oral
3) By Drug Class: Nsaids, Antibiotics, Corticosteroids
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Specialty Clinics, Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745
What regions are at the forefront of dengue treatment market expansion?
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the dengue treatment market?
Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20745&type=smp
What Is Covered In The Dengue Treatment Global Market Report?
•Market Size Forecast: Examine the dengue treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the dengue treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the dengue treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the dengue treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the dengue treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the dengue treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the dengue treatment market.
•Competitive Landscape: Review strategic developments in the dengue treatment market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Delivery System In XAFTY Improves Effectiveness Against Dengue here
News-ID: 3944830 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Dengue
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
Dengue Vaccines Market to Grow Globally
Dengue is a mosquito-borne flavivirus debilitating disease with high prevalence in most tropical and sub-tropical regions. Dengue is a painful disease that is also known as ‘break bone’ fever due to the excruciating bone and joint pain associated with it. No therapeutics have been discovered for treatment of the disease caused by four closely related dengue viruses (DEN-1, DEN-2, DEN-3 and DEN-4). Therefore, focus has been mainly on prevention by…
